ClinConnect ClinConnect Logo
Search / Trial NCT04583371

The Use of Pulmonary Hyperinflation With the Mechanical Ventilator in Cardiac Patients

Launched by INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL · Oct 5, 2020

Trial Information

Current as of May 23, 2025

Unknown status

Keywords

Physiotherapy Mechanical Ventilation

ClinConnect Summary

Mechanical ventilation (MV) is used to reduce work and reverse or prevent fatigue of the respiratory muscles, decrease oxygen consumption and maintain gas exchange. In addition to the benefits given to patients undergoing MV, there is a high risk of accumulating bronchial secretions, related to pathology and / or therapeutic intervention. Pulmonary hyperinflation is widespread in patients in intensive care centers (ICUs) as a bronchial hygiene therapy, being used in 40% of 64 Australian ICUs as demonstrated by Dennis et al., Through contact with physical therapists. Mechanical hyperinflatio...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Interned in the Post-Operative Unit (UPO), Intensive Care Center (ICU) and Emergency.
  • Using invasive mechanical ventilation for more than 48 hours.
  • Hemodynamically stable (MAP 60-120 mmHg).
  • Exclusion Criteria:
  • Diagnosis of ventilator-associated pneumonia.
  • Individuals with pneumothorax and undrained hemothorax.
  • Subcutaneous emphysema.
  • Patients with peak pressure\> 40 cmH2O.
  • Patients diagnosed with neurological disease within 72 hours.

About Instituto De Cardiologia Do Rio Grande Do Sul

The Instituto de Cardiologia do Rio Grande do Sul is a leading research and clinical institution dedicated to advancing cardiovascular health through innovative clinical trials and comprehensive patient care. Located in Brazil, the institute specializes in cardiology and is committed to enhancing the understanding and treatment of cardiovascular diseases. With a team of experienced healthcare professionals and researchers, the Instituto de Cardiologia do Rio Grande do Sul focuses on developing cutting-edge therapies and improving clinical outcomes, while fostering collaboration with national and international partners in the field of cardiovascular research.

Locations

Porto Alegre, Rio Grande Do Sul, Brazil

Patients applied

0 patients applied

Trial Officials

Bruna Eibel, Dr

Principal Investigator

Instituto de Cardiologia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials